Background: The treatment landscape has completely changed for advanced melanoma. We report survival outcomes and the differential impact of prognostic factors over time in daily clinical practice.Methods: From a Dutch nationwide population-based registry, patients with advanced melanoma diagnosed from 2013 to 2017 were analysed (n = 3616). Because the proportional hazards assumption was violated, a multivariable Cox model restricted to the first 6 months and a multivariable landmark Cox model from 6 to 48 months were used to assess overall survival (OS) of cases without missing values. The 2017 cohort was excluded from this analysis because of the short follow-up time.Results: Median OS of the 2013 and 2016 cohort was 11.7 months (95% conf...
Background: Mucosal melanoma (MM) is rare and has a poor prognosis. Since 2011, new effective treatm...
Alma B Pedersen,1,2 Søren P Johnsen,3,4 Erzsébet Horváth-Puhó2 1Department of Clinical Epidemiology,...
Introduction: When analysing patient survival, one is often interested in cause of death. Little is ...
Background: The treatment landscape has completely changed for advanced melanoma. We report survival...
Background: The treatment landscape has completely changed for advanced melanoma. We report survival...
Background: The treatment landscape has completely changed for advanced melanoma. We report survival...
Background: Mucosal melanoma (MM) is rare and has a poor prognosis. Since 2011, new effective treatm...
Background: Mucosal melanoma (MM) is rare and has a poor prognosis. Since 2011, new effective treatm...
Objective: The aim of this study was to evaluate treatment patterns and overall survival (OS) of pat...
Objective:The aim of this study was to evaluate treatment patterns and overall survival (OS) of pati...
OBJECTIVE: The aim of this study was to evaluate treatment patterns and overall survival (OS) of pat...
Background: Mucosal melanoma (MM) is rare and has a poor prognosis. Since 2011, new effective treatm...
Alma B Pedersen,1,2 Søren P Johnsen,3,4 Erzsébet Horváth-Puhó2 1Department of Clinical Epidemiology,...
Introduction: When analysing patient survival, one is often interested in cause of death. Little is ...
Background: The treatment landscape has completely changed for advanced melanoma. We report survival...
Background: The treatment landscape has completely changed for advanced melanoma. We report survival...
Background: The treatment landscape has completely changed for advanced melanoma. We report survival...
Background: Mucosal melanoma (MM) is rare and has a poor prognosis. Since 2011, new effective treatm...
Background: Mucosal melanoma (MM) is rare and has a poor prognosis. Since 2011, new effective treatm...
Objective: The aim of this study was to evaluate treatment patterns and overall survival (OS) of pat...
Objective:The aim of this study was to evaluate treatment patterns and overall survival (OS) of pati...
OBJECTIVE: The aim of this study was to evaluate treatment patterns and overall survival (OS) of pat...
Background: Mucosal melanoma (MM) is rare and has a poor prognosis. Since 2011, new effective treatm...
Alma B Pedersen,1,2 Søren P Johnsen,3,4 Erzsébet Horváth-Puhó2 1Department of Clinical Epidemiology,...
Introduction: When analysing patient survival, one is often interested in cause of death. Little is ...